Shanghai Henlius Biotech, Inc. Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Dec'25

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Net Sales

7,230.11

6,206.58

5,961.36

3,738.34

2,027.73

660.27

103.11

Other Operating Income

0.00

Total Operating income

7,230.11

6,206.58

5,961.36

3,738.34

2,027.73

660.27

103.11

Raw Material Cost

1,874.27

1,731.39

1,703.66

1,091.57

735.08

253.34

133.19

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

1,836.49

1,795.66

1,797.43

1,570.53

1,052.68

476.76

381.21

Power Cost

0.00

Manufacturing Expenses

111.16

133.24

122.15

122.88

102.23

49.11

54.78

Selling and Distribution Expenses

2,875.73

2,475.80

2,396.03

1,633.81

965.42

490.24

219.46

Other Expenses

-35.42

-86.85

-75.59

-18.11

-2.59

43.02

20.15

Total Expenditure (Excl Depreciation)

6,343.40

5,267.59

5,263.33

4,237.65

2,829.50

1,699.63

990.12

Operating Profit (PBDIT) excl Other Income

886.7

939

698

-499.3

-801.8000000000001

-1039.4

-887

Other Income

107.61

111.36

76.98

46.88

-248.89

-24.18

-29.26

Operating Profit (PBDIT)

1,460.03

1,456.73

1,171.96

-129.61

-809.40

-910.97

-822.73

Interest

111.16

133.24

122.15

122.88

102.23

49.11

54.78

Exceptional Items

-2.83

0.00

-23.48

-231.59

-0.19

-3.78

-20.91

Gross Profit (PBDT)

5,355.84

4,475.19

4,257.71

2,646.77

1,292.65

406.93

-30.08

Depreciation

465.71

406.37

396.95

322.82

241.25

152.57

93.55

Profit Before Tax

880.33

917.12

629.38

-806.91

-1,153.07

-1,116.44

-991.96

Tax

-16.61

27.55

26.03

1.60

32.92

0.00

0.74

Provisions and contingencies

0.00

Profit After Tax

896.95

889.57

603.35

-808.50

-1,185.99

-1,116.44

-992.70

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

896.95

889.57

603.35

-808.50

-1,185.99

-1,116.44

-992.70

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

896.95

889.57

603.35

-808.50

-1,185.99

-1,116.44

-992.70

Equity Capital

0.00

Face Value

1.11

1.06

1.1

1.12

1.22

1.19

1.12

Reserves

4,411.23

3,207.13

2,413.74

1,837.17

2,809.54

3,792.59

4,474.85

Earnings per share (EPS)

1.64

1.1

-1.49

-2.2

-2.11

-2.0

Diluted Earnings per share

1.64

1.1

-1.49

-2.2

-2.11

-2.0

Operating Profit Margin (Excl OI)

12.26%

15.13%

11.71%

-13.36%

-39.54%

-157.42%

-860.3%

Gross Profit Margin

18.62%

21.32%

17.22%

-12.95%

-44.97%

-145.98%

-871.35%

PAT Margin

12.41%

14.33%

10.12%

-21.63%

-58.49%

-169.09%

-962.8%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Dec 2025 is 16.49% vs 4.11% in Dec 2024

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 0.82% vs 47.46% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 0.52% vs 22.87% in Dec 2024

Interest

YoY Growth in year ended Dec 2025 is -16.52% vs 9.09% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Shanghai Henlius Biotech, Inc. With

Select Peers

Figures in Million

Consolidate Annual Results

Change(HKD)

Change(%)

Net Sales

7,230.11

8.06

7,222.05

89,603.60%

Other Operating Income

0.00

Total Operating income

7,230.11

8.06

7,222.05

89,603.60%

Raw Material Cost

1,874.27

53.43

1,820.84

3,407.90%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

1,836.49

87.05

1,749.44

2,009.70%

Power Cost

0.00

Manufacturing Expenses

111.16

7.03

104.13

1,481.22%

Selling and Distribution Expenses

2,875.73

61.85

2,813.88

4,549.52%

Other Expenses

-35.42

1.64

-37.06

-2,259.76%

Total Expenditure (Excl Depreciation)

6,343.40

225.73

6,117.67

2,710.17%

Operating Profit (PBDIT) excl Other Income

886.71

-217.66

1,104.37

507.38%

Other Income

107.61

6.80

100.81

1,482.50%

Operating Profit (PBDIT)

1,460.03

-158.07

1,618.10

1,023.66%

Interest

111.16

7.03

104.13

1,481.22%

Exceptional Items

-2.83

-3.34

0.51

15.27%

Gross Profit (PBDT)

5,355.84

-45.37

5,401.21

11,904.80%

Depreciation

465.71

52.80

412.91

782.03%

Profit Before Tax

880.33

-221.24

1,101.57

497.91%

Tax

-16.61

-0.27

-16.34

-6,051.85%

Provisions and contingencies

0.00

Profit After Tax

896.95

-220.94

1,117.89

505.97%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

896.95

-220.94

1,117.89

505.97%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

896.95

-220.94

1,117.89

505.97%

Equity Capital

0.00

Face Value

1.11

0.00

Reserves

4,411.23

688.44

3,722.79

540.76%

Earnings per share (EPS)

1.64

-0.53

2.17

409.43%

Diluted Earnings per share

1.64

-0.53

2.17

409.43%

Operating Profit Margin (Excl OI)

12.26%

-2,699.41%

0.00

2,711.67%

Gross Profit Margin

18.62%

-2,088.97%

0.00

2,107.59%

PAT Margin

12.41%

-2,740.08%

0.00

2,752.49%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 723.01 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 16.49% vs 4.11% in Dec 2024

Annual - Consolidate Net Profit

Consolidate Net Profit 89.69 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 0.82% vs 47.46% in Dec 2024

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 135.24 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is 0.52% vs 22.87% in Dec 2024

Annual - Interest

Interest 11.12 Million

in Dec 2025

Figures in Million

YoY Growth in year ended Dec 2025 is -16.52% vs 9.09% in Dec 2024

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 12.26%

in Dec 2025

Figures in %

YoY Growth in year ended Dec 2025 has fallen from Dec 2024